Trials@Home Podcast Miniseries: Episode One Overview
Clinical research is evolving. Traditional site-based clinical trials have long been the backbone of therapeutic development, but they also present real challenges: travel burden for participants, limited access for underserved populations, and escalating recruitment and retention pressures. The Trials@Home Consortium addresses these challenges by reshaping how and where research happens. This initiative champions decentralized clinical trials and hybrid models that bring elements of study participation directly to patients—enhancing accessibility, engagement, and equity across the research landscape.
At its core, Trials@Home promotes a shift from rigid, centralized trial activities toward a model that meets participants where they live. By integrating remote and in-home components into study design, this approach reduces the barriers that often dissuade patients from joining or completing trials. Driving a patient-centric approach not only supports participants through more flexible, comfortable trial experiences, but also helps sponsors and research teams increase recruitment and retention rates—key determinants of trial success in today’s competitive research environment.
One of the primary limitations of traditional clinical trials is the logistical burden placed on participants. Travel requirements, time away from work or family, and overlapping healthcare commitments can significantly hinder enrollment and continued involvement. The Trials@Home Consortium has worked to put recommendations and guidelines in place that mitigate these issues – encouraging many trial procedures—such as consent discussions, health assessments, remote monitoring, and data collection—to occur outside of the clinic or hospital setting. This flexibility makes clinical research more accessible for individuals who might otherwise be excluded due to distance, mobility limitations, or caregiver responsibilities.
Importantly, the Trials@Home consortium recognized that patient experience is integral to meaningful participation. Decentralized and hybrid trial models prioritize ease, comfort, and continuity of care – helping participants remain engaged throughout the course of a study. By empowering patients in familiar environments and reducing dependency on site-centric schedules, the DCT model enhances satisfaction and supports long-term retention, a persistent challenge in traditional trials.
The benefits of redefining access to clinical research extend beyond individual participants. For research sponsors and trial teams, incorporating decentralized elements can streamline operations, improve data quality, and shorten overall timelines. Reducing reliance on physical site visits decreases operational pressures, enabling trial staff to focus on high-impact activities and strategic planning. Moreover, as industry regulators and advocacy groups increasingly endorse patient-centric research models, decentralized designs are becoming essential tools in modern clinical operations.
Looking forward, the Trials@Home podcast series will explore these themes in depth. Future episodes will feature practical insights on design considerations, real-world case studies, and expert perspectives on navigating regulatory, technological, and operational complexities inherent in decentralized clinical trials. The goal is to provide listeners with actionable strategies to enhance trial accessibility and outcomes.
As the clinical research landscape becomes more complex, the recommendations made by the Trials@Home Consortium show how innovation and patient focus can create a more inclusive, efficient, and sustainable future for trials. By lowering participation barriers and empowering participants, the decentralized and hybrid models helps ensure that clinical research serves a broader and more diverse population.
Follow MRN on LinkedIn for more updates and podcasts about our involvement in the Trials@Home Consortium.
For more about the Trials@Home Consortium and to access their recommendations you can visit https://trialsathome.com/ or follow them on LinkedIn.